These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27618103)

  • 21. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.
    Chen W; Xiao BK; Liu JP; Chen SM; Tao ZZ
    Cancer Sci; 2010 Aug; 101(8):1769-76. PubMed ID: 20545697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
    Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
    J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
    Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer.
    Ding D; Zhou J; Wang M; Cong YS
    FEBS J; 2013 Jul; 280(14):3205-11. PubMed ID: 23527617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review).
    Qin Y; Guo H; Tang B; Yang SM
    Int J Oncol; 2014 Aug; 45(2):525-31. PubMed ID: 24888567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
    Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
    J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine/threonine-protein phosphatase 2A physically interacts with human telomerase reverse transcriptase hTERT and regulates its subcellular distribution.
    Xi P; Zhou L; Wang M; Liu JP; Cong YS
    J Cell Biochem; 2013 Feb; 114(2):409-17. PubMed ID: 22961627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated expression of hTERT is associated with dysplastic cell transformation during human oral carcinogenesis in situ.
    Kim HR; Christensen R; Park NH; Sapp P; Kang MK; Park NH
    Clin Cancer Res; 2001 Oct; 7(10):3079-86. PubMed ID: 11595698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development.
    Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
    Int J Cancer; 2001 Mar; 91(5):644-9. PubMed ID: 11267974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere and Telomerase Therapeutics in Cancer.
    Xu Y; Goldkorn A
    Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.